Compare CLLS & KOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CLLS | KOS |
|---|---|---|
| Founded | 1999 | 2003 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 476.5M | 475.3M |
| IPO Year | 2007 | 2011 |
| Metric | CLLS | KOS |
|---|---|---|
| Price | $4.99 | $0.89 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 5 |
| Target Price | ★ $8.50 | $2.00 |
| AVG Volume (30 Days) | 112.6K | ★ 17.0M |
| Earning Date | 11-07-2025 | 11-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $82,551,000.00 | ★ $1,392,234,000.00 |
| Revenue This Year | $32.58 | N/A |
| Revenue Next Year | $20.68 | $18.18 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 129.04 | N/A |
| 52 Week Low | $1.10 | $0.84 |
| 52 Week High | $5.48 | $4.01 |
| Indicator | CLLS | KOS |
|---|---|---|
| Relative Strength Index (RSI) | 57.74 | 30.78 |
| Support Level | $4.67 | $0.84 |
| Resistance Level | $5.03 | $1.06 |
| Average True Range (ATR) | 0.28 | 0.08 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 67.51 | 19.20 |
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.
Kosmos Energy Ltd is a deepwater exploration and production company focused on meeting the world's growing demand for energy. It has diversified oil and gas production from assets offshore Ghana, Equatorial Guinea, Mauritania, Senegal and the Gulf of America. The Company had operations in four geographic reporting segments: Ghana, Equatorial Guinea, Mauritania/Senegal and the Gulf of America. The majority of revenue is derived from the Ghana segment.